Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 373 Neoplasms 323 Neoplasm Metastasis 286 Leukemia, Myeloid, Acute 277 Breast Neoplasms 271 Colorectal Neoplasms 238 Melanoma 194 Ovarian Neoplasms 191 Recurrence 183 Multiple Myeloma 179 Prostatic Neoplasms 156 Lung Neoplasms 156 Pancreatic Neoplasms 153 Squamous Cell Carcinoma of Head and Neck 150 Lymphoma, Non-Hodgkin 146 Glioblastoma 145 Triple Negative Breast Neoplasms 120 Myelodysplastic Syndromes 114 Carcinoma, Renal Cell 111 Stomach Neoplasms 110 Glioma 108 Advanced Solid Tumors 106 Brain Neoplasms 105 Precursor Cell Lymphoblastic Leukemia-Lymphoma 103 Lymphoma, Large B-Cell, Diffuse 101 Lymphoma 100 Lymphoma, B-Cell 98 Carcinoma, Hepatocellular 95 Endometrial Neoplasms 92 Lymphoma, Follicular 91

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × mCRC × 1 year × Clear all

NCT07543471 2026-04-24

PK similarity

Shanghai Henlius Biotech

Phase 1 Not yet recruiting

mCRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡